Answers are grounded in this paper and cite their sources.
Prospective study examines timing of hyperemia for combination therapy in hepatocellular carcinoma.
Purpose Combination treatments—thermal ablation (TA) and transarterial chemoembolisation (TACE) have been suggested for hepatocellular carcinoma (HCC). After TA a transient hyperemic zone appears around the ablated area, a potential target for TACE. The aim was to determine when this peri-ablational hyperemia is at its widest and most intensely perfused. Materials and methods This prospective study examined the hepatic peri-ablation zones with contrast-enhanced ultrasound (CEUS) in both arterial and portal venous phases, at 0, 2, 6, and 24 h after microwave ablation (MWA). Subjects were stratified into two groups, cirrhosis and non-cirrhosis. Quantitative software was used to determine relative tissue perfusion, rendering a hyperemia-to-normal liver (HTNL) ratio. The width of the hyperemic zone was measured on each arterial phase (AP). Results In total, 34 patients (cirrhosis n = 17, non-cirrhosis = 17) were included in this study. The hyperemia was arterially supplied with a HTNL of 567.5% at 0 h for the overall group. The AP median HTNL- ratio decrease for the overall group was: –158.9 (2 h), -283.8 (6 h), and –270.9 (24 h) (absolute change in percentage points). No difference was seen between cirrhotic and non-cirrhotic livers. The change in width on the AP for the overall group decreased from 12 mm to -2 mm (2 h), -3 mm (6 h), and -5 mm (24 h). Conclusion The peri-ablational hyperemia is arterially supplied and peaks in intensity and width immediately after TA, then declines steeply.
No takes yet. Share an insight, caveat, or question.
Svensson et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: